Company Information

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE258.25-13.55 (-4.99 %)
PREV CLOSE ( ) 271.80
OPEN PRICE ( ) 258.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40211
TODAY'S LOW / HIGH ( )258.25 258.25
52 WK LOW / HIGH ( )178.1 474
NSE257.35-13.55 (-5 %)
PREV CLOSE( ) 270.90
OPEN PRICE ( ) 257.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 257.35 (1122322)
VOLUME 592866
TODAY'S LOW / HIGH( ) 257.35 257.35
52 WK LOW / HIGH ( )178.8 472.8
ChairmanDilip S Shanghvi
Company SecretaryKajal Damania
Non Executive DirectorT Rajamannar
Promoter & Non-Executive DirectorSudhir V Valia
Non Executive Independent DirectorBhavna Doshi
Ferzaan Engineer
Robert J Spiegel
Incorporation Year : 31-03 2006

Registered Office :

Address : Plot No.5 & 6/1, Savli G. I. D. C. Estate,Savli - Vadodara Highway,Manjusar Vadodara,
Gujarat-391775 .

Phone : 0265- 2330815

Industry : Business Support

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.